Arena Pharmaceuticals’ $1.2 Billion Agreement With United Therapeutics

Ambrogio Visconti
Tagged:

Cooley advised Arena Pharmaceuticals on its global license agreement with United Therapeutics for Arena’s drug candidate ralinepag, a next-generation treatment of pulmonary arterial hypertension (PAH). Arena…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now